CVE-2024-6368
Published: 27 June 2024
Summary
CVE-2024-6368 is a medium-severity Cross-site Scripting (CWE-79) vulnerability in Labvantage Laboratory Information Management System. Its CVSS base score is 5.3 (Medium).
Operationally, exploitation aligns with the MITRE ATT&CK technique JavaScript (T1059.007); ranked at the 31.9th percentile by exploit likelihood (below the median); it is not currently listed in the CISA KEV catalog; a public proof-of-concept is referenced.
EU & UK References
- 🇪🇺 ENISA EUVD: EUVD-2024-47475
Vulnerability details
A vulnerability was found in LabVantage LIMS 2017. It has been rated as problematic. This issue affects some unknown processing of the file /labvantage/rc?command=page of the component POST Request Handler. The manipulation of the argument param1 leads to cross site…
more
scripting. The attack may be initiated remotely. The exploit has been disclosed to the public and may be used. The identifier VDB-269801 was assigned to this vulnerability. NOTE: The vendor was contacted early about this disclosure but did not respond in any way.
- CWE(s)
Related Threats
MITRE ATT&CK Enterprise TechniquesAI
Why these techniques?
Reflected XSS in public-facing web endpoint (/labvantage/rc?command=page) enables exploitation of public-facing application (T1190) to inject and execute JavaScript in victim browser context (T1059.007).
Affected Assets
Mitigating Controls
Likely Mitigating Controls AI
Per-CVE control mapping for this CVE has not run yet; the list below is derived from the weakness types (CWEs) cited in the NVD entry.
Penetration testing submits XSS payloads to web applications, detecting cross-site scripting flaws for subsequent remediation.
Validates web inputs to reject script-related content that could produce XSS.
Output validation against expected content can reject or sanitize script content in generated web pages, reducing XSS exploitability.